| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |